相关临床试验
0
0 进行中
药物批准
8
批准总数
监管机构
1
监管机构数
成立时间
N/A
暂无试验阶段数据
暂无试验数据
暂无试验数据
<p><strong>4.1 THERAPEUTIC INDICATIONS</strong></p> <p>Aklief is indicated for the topical treatment of <em>Acne Vulgaris</em> of the face and/or the trunk in patients from 12 years of age and older, when many comedones, papules and/or pustules are present.</p>
<p><strong>INDICATIONS AND CLINICAL USE</strong><br> EPIDUO FORTE Gel (adapalene 0.3%/benzoyl peroxide 2.5%) is indicated for:</p> <ul> <li>Treatment of acne vulgaris, characterized by comedones, inflammatory papules/pustules with or without occasional nodules in patients 12 years of age and older. (See Clinical Trials Section – <em>please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information</em>)</li> </ul>
**INDICATIONS AND CLINICAL USE** Clobex Lotion (clobetasol propionate lotion, 0.05%) is a highly potent corticosteroid with the potential to suppress the HPA axis. Clobex Lotion is indicated for the treatment of moderate to severe corticosteroid-responsive dermatoses where an anti-inflammatory or anti-pruritic activity is required for the topical management of these conditions. Treatment should be limited to 2 consecutive weeks, not to exceed 50 grams (50 mL or 1.75 fl. oz.) per week, and be applied to no more than 10% of the body surface area. Use should be restricted to those 18 years or older. In the treatment of moderate to severe plaque-type psoriasis that has not sufficiently improved after the initial 2 weeks, Clobex Lotion can be used for up to 2 additional weeks. Any additional benefits of extending treatment should be weighed against the risk of HPA axis suppression. Patients should be instructed to use Clobex Lotion for the minimum amount of time necessary. _Use in patients younger than 18 years of age in not recommended due to numerically high rates of HPA axis suppression._
<p><strong>Indication:</strong><br> Desonide (Desowen) Cream 0.05% and Lotion 0.05% are indicated for the relief of the inflammatory and pruritic manifestation of corticosteroid-responsive dermatoses.</p>
**Indication:** Desonide (Desowen) Cream 0.05% and Lotion 0.05% are indicated for the relief of the inflammatory and pruritic manifestation of corticosteroid-responsive dermatoses.
**INDICATIONS AND USAGE** **Loceryl Nail Lacquer** is indicated in the topical treatment of nail fungal infections (onychomycosis) caused by dermatophytes, yeasts and moulds.
暂无资讯文章
